| Synonyms: | |
| Status: | Approved (2021) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | TO3JYR3BOU |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Complement C3 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Anemia, Hemolytic, Autoimmune | 3 | D000744 | ClinicalTrials |
| Geographic Atrophy | 3 | D057092 | ClinicalTrials |
| Hemoglobinuria | 3 | D006456 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
| Thrombotic Microangiopathies | 2 | D057049 | ClinicalTrials |
| Glomerulonephritis, Membranoproliferative | 2 | D015432 | ClinicalTrials |
| Macular Degeneration | 1 | D008268 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298211 |
| FDA SRS | TO3JYR3BOU |
CONTENTS